Respicardia Announces First U.S. Commercial Case With The remedē ®System
Industry Veteran Peter Sommerness Joins as CEO to Lead U.S. Launch
TREATING
CENTRAL SLEEP APNEA
Press Releases
Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea
Company announces strategic relationship with ZOLL Medical
Respicardia’s remedē ® System Receives FDA Approval
Breakthrough Treatment of Moderate to Severe Central Sleep Apnea in Adult Patients Now Available